×
About 21,305 results

ALLMedicine™ Pancreatitis Center

Research & Reviews  7,465 results

Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing...
https://doi.org/10.1136/gutjnl-2021-325855
Gut Olesen SS, Phillips AE et. al.

Oct 23rd, 2021 - Several factors have been suggested to mediate pain in patients with chronic pancreatitis. However, it is unknown whether these factors are overlapping and if they have cumulative effects on patient-reported outcomes (PROs). We performed a multice...

Hurdles in ERCP trials: do we need to change the diagnostic criteria for post-ERCP panc...
https://doi.org/10.1016/j.cgh.2021.10.019
Clinical Gastroenterology and Hepatology : the Official C... Chong B, Cote GA

Oct 22nd, 2021 - Hurdles in ERCP trials: do we need to change the diagnostic criteria for post-ERCP pancreatitis?|2021|Chong B,Cote GA,|

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Re...
https://doi.org/10.14309/ajg.0000000000001527
The American Journal of Gastroenterology; Ramsey ML, Gokun Y et. al.

Oct 20th, 2021 - Acute pancreatitis (AP) occurs among patients with pancreas-sufficient cystic fibrosis (PS-CF) but is reportedly less common among patients with pancreas-insufficient cystic fibrosis (PI-CF). The incidence of AP may be influenced by cystic fibrosi...

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
https://clinicaltrials.gov/ct2/show/NCT05082519

Oct 19th, 2021 - GOALS AND OBJECTIVES Hypothesis: Caloric restriction with increased physical activity integrated into induction chemotherapy will decrease chemoresistance and reduce minimal residual disease (MRD). In children receiving induction therapy for NCI/R...

Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery.
https://doi.org/10.3791/55332
Journal of Visualized Experiments : JoVE; Fusco JC, Congde C et. al.

Oct 19th, 2021 - The pancreas is a bifunctional organ with both endocrine and exocrine components. A number of pathologies can afflict the pancreas, including diabetes, pancreatitis, and pancreatic cancer. All three of these diseases mark active areas of study, no...

see more →

Guidelines  27 results

Enhanced EUS imaging (with videos).
https://doi.org/10.1016/j.gie.2020.06.075
Gastrointestinal Endoscopy; Krishnan K, Bhutani MS et. al.

Nov 2nd, 2020 - EUS remains a primary diagnostic tool for the evaluation of pancreaticobiliary disease. Although EUS combined with FNA or biopsy sampling is highly sensitive for the diagnosis of neoplasia within the pancreaticobiliary tract, limitations exist in ...

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Pr...
https://doi.org/10.1210/clinem/dgaa674
The Journal of Clinical Endocrinology and Metabolism; Newman CB, Blaha MJ et. al.

Sep 21st, 2020 - This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglyceride-induced p...

International consensus guidelines on interventional endoscopy in chronic pancreatitis....
https://doi.org/10.1016/j.pan.2020.05.022
Pancreatology : Official Journal of the International Ass... Kitano M, Gress TM et. al.

Aug 15th, 2020 - This paper is part of the international consensus guidelines on chronic pancreatitis, presenting for interventional endoscopy. An international working group with experts on interventional endoscopy evaluated 26 statements generated from evidence ...

International consensus guidelines on the role of diagnostic endoscopic ultrasound in t...
https://doi.org/10.1016/j.pan.2020.05.025
Pancreatology : Official Journal of the International Ass... Mel Wilcox C, Gress T et. al.

Jul 8th, 2020 - Chronic pancreatitis (CP) is a complex inflammatory disease with variable presentations and outcomes. This statement is part of the international consensus guidelines on CP, specifically on the diagnostic role of endoscopic ultrasound (EUS). An in...

International consensus guidelines on surveillance for pancreatic cancer in chronic pan...
https://doi.org/10.1016/j.pan.2020.05.011
Pancreatology : Official Journal of the International Ass... Greenhalf W, Lévy P et. al.

Jul 7th, 2020 - Patients with chronic pancreatitis (CP) have an increased risk of pancreatic cancer. We present the international consensus guidelines for surveillance of pancreatic cancer in CP. The international group evaluated 10 statements generated from evid...

see more →

Drugs  358 results see all →

Clinicaltrials.gov  136 results

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
https://clinicaltrials.gov/ct2/show/NCT05082519

Oct 19th, 2021 - GOALS AND OBJECTIVES Hypothesis: Caloric restriction with increased physical activity integrated into induction chemotherapy will decrease chemoresistance and reduce minimal residual disease (MRD). In children receiving induction therapy for NCI/R...

A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive.
https://clinicaltrials.gov/ct2/show/NCT04455815

Oct 13th, 2021 - Coronavirus-induced disease 2019 (COVID-19) caused by SARS-CoV-2 infection is a highly contagious disease with a high and unpredictable morbidity and mortality, for which there is currently no specific treatment. Progression from a mild fatigue, f...

Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis
https://clinicaltrials.gov/ct2/show/NCT05073614

Oct 11th, 2021 - Chronic gastritis (CG) is a very common disease. The incidence of CG is not accurately known. However, it is clear that the incidence of CG is increasing by advancing age. CG is divided into two main types; type A or immune and type B or non-immun...

Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation
https://clinicaltrials.gov/ct2/show/NCT05068739

Oct 6th, 2021 - Cannulation success with standard techniques reported to be around 95% even in expert hands and despite all efforts, it can be challenging that needs an alternate intervention. NKF is recommended as the initial technique for pre-cutting because th...

Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer
https://clinicaltrials.gov/ct2/show/NCT03158779

Oct 6th, 2021 - The aim of this prospective mono-institutional phase II study is to assess the efficacy and safety of sequentially integrated treatment of FOLFIRINOX or Gemcitabine-Abraxane and SBRT with a total dose of 54 Gy in 6 fractions of 9 Gy /fractions in ...

see more →

News  523 results

Immediate Drainage Not Superior in Patients With Infected Necrotizing Pancreatitis
https://www.medscape.com/viewarticle/960398

Oct 7th, 2021 - (Reuters Health) - Immediately draining an infected necrotizing pancreas does not prevent complications any better than postponing the procedure, according to a new test in 104 patients reported in the New England Journal of Medicine. Immediate dr...

Optimal AE Management Required With Immunotherapy in Melanoma
https://www.onclive.com/view/optimal-ae-management-required-with-immunotherapy-in-melanoma

Oct 6th, 2021 - Kathleen Madden, FNP, MSN, AOCNP, APHN, APHN Being able to quickly detect and properly manage adverse events (AEs) that arise in patients with melanoma who are receiving immunotherapy is key to improving their experience with treatment, explained...

Atezolizumab/Bevacizumab Demonstrates Durable Efficacy in Advanced Malignant Peritoneal Mesothelioma
https://www.onclive.com/view/atezolizumab-bevacizumab-demonstrates-durable-efficacy-in-advanced-malignant-peritoneal-mesothelioma

Oct 6th, 2021 - The combination of atezolizumab (Tecentriq) plus bevacizumab (Avastin) elicited encouraging, durable responses in patients with advanced malignant peritoneal mesothelioma, irrespective of tumor mutational burden (TMB) and PD-L1 expression status, ...

Taking Steps to Manage Adverse Events Associated with Checkpoint Inhibitors
https://www.onclive.com/view/taking-steps-to-manage-adverse-events-associated-with-checkpoint-inhibitors

Oct 6th, 2021 - Igor Puzanov, MD, MSCI, FACP Director, Early Phase Clinical Trials Program Chief of Melanoma Section Co-Leader, CCSG Experimental Therapeutics Program Professor of Oncology in the Department of Medicine Roswell Park Cancer Institute Immune...

DKK3 Gene Linked to Pancreatic Adenocarcinoma Proliferation
https://www.onclive.com/view/dkk3-gene-linked-to-pancreatic-adenocarcinoma-proliferation

Oct 6th, 2021 - Rosa Hwang, MD An investigational antibody directed against Dickkopf-3 (DKK3) may be the key in suppressing tumor growth and extending survival in patients with pancreatic adenocarcinoma, according to a recent preclinical study published in Scien...

see more →

Patient Education  13 results see all →